Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Head and Neck Cancer

  Free Subscription


Articles published in Thyroid

Retrieve available abstracts of 286 articles:
HTML format
Text format



Single Articles


    June 2018
  1. TRAN BM, Roshan DJ, Abraham E, Wang LY, et al
    The Prognostic Impact of Tumor Size in Papillary Thyroid Carcinoma is Modified by Age.
    Thyroid. 2018 Jun 19. doi: 10.1089/thy.2017.0607.
    PubMed     Text format     Abstract available


    May 2018
  2. HE H, Li W, Yan P, Bundschuh R, et al
    Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.
    Thyroid. 2018 May 16. doi: 10.1089/thy.2017.0258.
    PubMed     Text format     Abstract available


  3. CHU KP, Baker SP, Zenke JK, Morad A, et al
    Low-Activity Radioactive Iodine Therapy for Thyroid Carcinomas Exhibiting Nodal Metastases and Extrathyroidal Extension May Lead to Early Disease Recurrence.
    Thyroid. 2018 May 10. doi: 10.1089/thy.2017.0136.
    PubMed     Text format     Abstract available


  4. CABANILLAS M, Ferrarotto R, Garden A, Ahmed S, et al
    Neoadjuvant BRAF- and immune- directed therapy for anaplastic thyroid carcinoma.
    Thyroid. 2018 May 10. doi: 10.1089/thy.2018.0060.
    PubMed     Text format     Abstract available



  5. Correction to: Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study, by Kim M, Kim TH, Shin DY, Lim DJ, Kim EY, Kim WB, Chung JH, Shong YK, Kim BH, an
    Thyroid. 2018;28:686.
    PubMed     Text format    


    March 2018
  6. ROSARIO PW
    Re: "A Follow-Up Strategy for Patients with Excellent Response to Initial Therapy for Differentiated Thyroid Carcinoma" by Jeon et al. (Thyroid 2018;28:187-192).
    Thyroid. 2018 Mar 27. doi: 10.1089/thy.2017.0644.
    PubMed     Text format    


    February 2018
  7. LEI J, Zhong J, Li Z, Wei T, et al
    A nomogram based on the characteristics of metastatic lymph nodes to predict papillary thyroid carcinoma recurrence.
    Thyroid. 2018 Feb 14. doi: 10.1089/thy.2017.0422.
    PubMed     Text format     Abstract available


  8. KIM M, Jeon M, Oh HS, Park S, et al
    <i>BRAF</i> and <i>RAS</i> mutational status in non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive subtype of encapsulated follicular variant of papillary thyroid carcinoma in Korea.
    Thyroid. 2018 Feb 14. doi: 10.1089/thy.2017.0382.
    PubMed     Text format     Abstract available


  9. HIRSCH D, Twito O, Levy S, Bachar G, et al
    Temporal Trends in the Presentation, Treatment, and Outcome of Medullary Thyroid Carcinoma - An Israeli Multicenter Study.
    Thyroid. 2018 Feb 5. doi: 10.1089/thy.2017.0371.
    PubMed     Text format     Abstract available


    January 2018
  10. LUBITZ CC, Zhan T, Gunda V, Amin S, et al
    Circulating BRAFV600E levels correlate with treatment in patients with thyroid carcinoma.
    Thyroid. 2018 Jan 29. doi: 10.1089/thy.2017.0322.
    PubMed     Text format     Abstract available


  11. JAHANBANI I, Al-Abdallah A, Ali R, Al-Brahim N, et al
    Discriminatory miRNAs for the management of papillary thyroid carcinoma and noninvasive follicular thyroid neoplasms with papillary-like nuclear features.
    Thyroid. 2018 Jan 29. doi: 10.1089/thy.2017.0127.
    PubMed     Text format     Abstract available


  12. KIM M, Kim TH, Shin DY, Lim DJ, et al
    Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study.
    Thyroid. 2018 Jan 19. doi: 10.1089/thy.2017.0356.
    PubMed     Text format     Abstract available


  13. OH HS, Kwon H, Song E, Jeon M, et al
    Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
    Thyroid. 2018 Jan 19. doi: 10.1089/thy.2017.0514.
    PubMed     Text format     Abstract available


  14. KIM MJ, Won JK, Jung KC, Kim JH, et al
    Clinical characteristics of subtypes of follicular variant papillary thyroid carcinoma.
    Thyroid. 2018 Jan 17. doi: 10.1089/thy.2016.0671.
    PubMed     Text format     Abstract available


  15. CARVALHO M, Rosario PW, Mourao GF, Oliveira LFF, et al
    Clinical impact of detectable antithyroglobulin antibodies below the reference limit (borderline) in patients with papillary thyroid carcinoma with negative serum thyroglobulin and neck ultrasonography after ablation: a prospective study.
    Thyroid. 2018 Jan 12. doi: 10.1089/thy.2017.0350.
    PubMed     Text format     Abstract available


    November 2017
  16. JEON M, Kim M, Park S, Oh HS, et al
    A follow-up strategy for patients with excellent response to initial therapy for differentiated thyroid carcinoma : less is better.
    Thyroid. 2017 Nov 27. doi: 10.1089/thy.2017.0130.
    PubMed     Text format     Abstract available


  17. WATUTANTRIGE-FERNANDO S, Vianello F, Barollo S, Bertazza L, et al
    The Hobnail variant of Papillary Thyroid Carcinoma: clinical/molecular characteristics of a large monocentric series and comparison with conventional histotypes.
    Thyroid. 2017 Nov 27. doi: 10.1089/thy.2017.0248.
    PubMed     Text format     Abstract available


  18. IYER P, Dadu R, Ferrarotto R, Busaidy N, et al
    Real world experience with targeted therapy for the treatment of anaplastic thyroid carcinoma.
    Thyroid. 2017 Nov 22. doi: 10.1089/thy.2017.0285.
    PubMed     Text format     Abstract available


  19. KLEIN HESSELINK MS, Bocca G, Hummel YM, Brouwers AH, et al
    Diastolic dysfunction is common in survivors of pediatric differentiated thyroid carcinoma.
    Thyroid. 2017 Nov 13. doi: 10.1089/thy.2017.0383.
    PubMed     Text format     Abstract available


  20. NAM SH, Roh JL, Gong G, Cho KJ, et al
    Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
    Thyroid. 2017 Nov 8. doi: 10.1089/thy.2017.0334.
    PubMed     Text format     Abstract available


  21. KUO EJ, Thi WJ, Zheng F, Zanocco K, et al
    Individualizing surgery in papillary thyroid carcinoma based on a detailed sonographic assessment of extrathyroidal extension.
    Thyroid. 2017 Nov 7. doi: 10.1089/thy.2017.0457.
    PubMed     Text format     Abstract available


    October 2017
  22. SCHMOHL KA, Dolp P, Schug C, Knoop K, et al
    Reintroducing the sodium iodide symporter (NIS) to anaplastic thyroid carcinoma.
    Thyroid. 2017 Oct 15. doi: 10.1089/thy.2017.0290.
    PubMed     Text format     Abstract available


    September 2017
  23. CANO JM, Galan R, Lopez R
    Recurrent Metastatic Medullary Thyroid Carcinoma: A Case of Sustained Response to Prolonged Treatment with Somatostatin Analogues.
    Thyroid. 2017.
    PubMed     Text format     Abstract available


  24. YAPA S, Mulla O, Green V, England J, et al
    The Role of Chemokines in Thyroid Carcinoma.
    Thyroid. 2017 Sep 11. doi: 10.1089/thy.2016.0660.
    PubMed     Text format     Abstract available


  25. RUIZ-FERRER M, Fernandez RM, Navarro E, Antinolo G, et al
    <i>ESR2</i> gene and Medullary Thyroid Carcinoma.
    Thyroid. 2017 Sep 11. doi: 10.1089/thy.2017.0171.
    PubMed     Text format     Abstract available


    August 2017
  26. HALL S, Irish JC, Groome PA, Griffiths R, et al
    Do lower risk thyroid cancer patients who live in regions with more aggressive treatments have better outcomes?
    Thyroid. 2017 Aug 29. doi: 10.1089/thy.2017.0103.
    PubMed     Text format     Abstract available


  27. CHINN SB, Zafereo M, Waguespack SG, Edeiken BS, et al
    Long-term outcomes of lateral neck dissection in patients with recurrent or persistent well-differentiated thyroid cancer.
    Thyroid. 2017 Aug 15. doi: 10.1089/thy.2017.0203.
    PubMed     Text format     Abstract available


  28. VALDERRABANO P, Khazai L, Thompson ZJ, Leon ME, et al
    Cancer risk stratification of indeterminate thyroid nodules: A cytological approach.
    Thyroid. 2017 Aug 15. doi: 10.1089/thy.2017.0221.
    PubMed     Text format     Abstract available


  29. WHITE PS, Pudusseri A, Lee SL, Eton O, et al
    Intermittent Dosing of Dabrafenib and Trametinib in Metastatic BRAFV600E Mutated Papillary Thyroid Cancer: Two Case Reports.
    Thyroid. 2017 Aug 12. doi: 10.1089/thy.2017.0106.
    PubMed     Text format     Abstract available


  30. RUHLMANN M, Ruhlmann J, Gorges R, Herrmann K, et al
    18F-FDG PET/CT may exclude malignancy in sonographically suspicious and scintigraphically hypofunctional thyroid nodules and reduce unnecessary thyroid surgeries.
    Thyroid. 2017 Aug 10. doi: 10.1089/thy.2017.0026.
    PubMed     Text format     Abstract available


  31. ROBENSHTOK E, Nachalon Y, Benbassat C, Hirsch D, et al
    Disease Severity at Presentation in Patients with Disease-Related Mortality from Differentiated Thyroid Cancer: Implications for the 2015 ATA Guidelines.
    Thyroid. 2017 Aug 9. doi: 10.1089/thy.2017.0040.
    PubMed     Text format     Abstract available


  32. SUH CH, Choi YJ, Lee JJ, Shim WH, et al
    Comparison of Core-Needle Biopsy and Fine-Needle Aspiration for Evaluating Thyroid Incidentalomas Detected by 18F-FDG PET/CT: A Propensity Score Analysis.
    Thyroid. 2017 Aug 9. doi: 10.1089/thy.2017.0192.
    PubMed     Text format     Abstract available


  33. HA SM, Baek JH, Kim JK
    Detection of malignancy among suspicious thyroid nodules less than 1 cm on ultrasound with various thyroid image reporting and data systems.
    Thyroid. 2017 Aug 9. doi: 10.1089/thy.2017.0034.
    PubMed     Text format     Abstract available


    July 2017
  34. OH HS, Park S, Kim M, Kwon H, et al
    Young age and male sex can predict for a large-volume central neck lymph node metastasis in clinical N0 papillary thyroid microcarcinoma.
    Thyroid. 2017 Jul 25. doi: 10.1089/thy.2017.0250.
    PubMed     Text format     Abstract available


  35. ALHASHEMI A, Jones J, Goldstein DP, Santa Mina D, et al
    An Exploratory Study of Fatigue and Physical Activity in Canadian Thyroid Cancer Patients.
    Thyroid. 2017 Jul 16. doi: 10.1089/thy.2016.0541.
    PubMed     Text format     Abstract available


  36. HAHN SY, Shin JH, Oh YL, Kim TH, et al
    Role of Ultrasound in Predicting Tumor Invasiveness in Follicular Variant of Papillary Thyroid Carcinoma.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2016.0677.
    PubMed     Text format     Abstract available


  37. PARK S, Kim WG, Han M, Jeon M, et al
    Thyroid-Stimulating Hormone Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2017.0177.
    PubMed     Text format     Abstract available


    June 2017
  38. KIYOTA N, Robinson B, Shah MH Md, Hoff AO, et al
    Defining Radioiodine-refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-refractory Criteria in the SELECT Trial.
    Thyroid. 2017 Jun 30. doi: 10.1089/thy.2016.0549.
    PubMed     Text format     Abstract available


  39. TANG AL, Falciglia M, Yang H, Mark JR, et al
    Validation of ATA Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine Needle Aspiration.
    Thyroid. 2017 Jun 28. doi: 10.1089/thy.2016.0555.
    PubMed     Text format     Abstract available


  40. KLUBO-GWIEZDZINSKA J, Yang LA, Merkel R, Patel D, et al
    Results of screening in familial nonmedullary thyroid cancer.
    Thyroid. 2017 Jun 28. doi: 10.1089/thy.2016.0668.
    PubMed     Text format     Abstract available


  41. ITO Y, Onoda N, Ito KI, Sugitani I, et al
    Sorafenib in Japanese Patients With Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
    Thyroid. 2017 Jun 21. doi: 10.1089/thy.2016.0621.
    PubMed     Text format     Abstract available


  42. KIM M, Kim WG, Oh HS, Park S, et al
    Comparison of the 7th and 8th Editions of the AJCC/UICC TNM Staging System for Differentiated Thyroid Cancer.
    Thyroid. 2017 Jun 21. doi: 10.1089/thy.2017.0050.
    PubMed     Text format     Abstract available


  43. SILVA-VIEIRA M, Carrilho-Vaz S, Esteves S, C Ferreira T, et al
    Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
    Thyroid. 2017 Jun 14. doi: 10.1089/thy.2016.0655.
    PubMed     Text format     Abstract available


  44. PILLI T, Cantara S, Marzocchi C, Cardinale S, et al
    Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients.
    Thyroid. 2017 Jun 12. doi: 10.1089/thy.2017.0035.
    PubMed     Text format     Abstract available


    May 2017
  45. GONZALEZ HE, Martinez JR, Vargas S, Solar A, et al
    A 10-gene classifier for indeterminate thyroid nodules: Development and multicenter accuracy study.
    Thyroid. 2017 May 18. doi: 10.1089/thy.2017.0067.
    PubMed     Text format     Abstract available


  46. POLE JD, Zuk AM, Wasserman JD
    Diagnostic and Treatment Patterns among Children, Adolescents and Young Adults with Thyroid Cancer in Ontario: 1992-2010.
    Thyroid. 2017 May 17. doi: 10.1089/thy.2016.0629.
    PubMed     Text format     Abstract available


  47. RANDLE RW, Bushman NM, Orne J, Balentine CJ, et al
    PAPILLARY THYROID CANCER: THE GOOD AND BAD OF THE "GOOD CANCER".
    Thyroid. 2017 May 16. doi: 10.1089/thy.2016.0632.
    PubMed     Text format     Abstract available


  48. WILSON L, Huang W, Chen L, Ting J, et al
    Cost-Effectiveness of Lenvatinib, Sorafenib, and Placebo in the Treatment of Radioiodine Refractory Differentiated Thyroid Cancer.
    Thyroid. 2017 May 9. doi: 10.1089/thy.2016.0572.
    PubMed     Text format     Abstract available


  49. HEDMAN C, Djarv T, Strang P, Lundgren CI, et al
    The effect of thyroid-related symptoms on long-term quality of life in patients with differentiated thyroid carcinoma - a population-based study in Sweden.
    Thyroid. 2017 May 5. doi: 10.1089/thy.2016.0604.
    PubMed     Text format     Abstract available


  50. INIGUEZ ARIZA NM, Ryder M, Hilger CR, Bible KC, et al
    Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer.
    Thyroid. 2017 May 4. doi: 10.1089/thy.2016.0627.
    PubMed     Text format     Abstract available


  51. KIM M, Kim WG, Park S, Kwon H, et al
    Growth Kinetics of Macronodular Lung Metastases and Survival in Differentiated Thyroid Carcinoma.
    Thyroid. 2017 May 2. doi: 10.1089/thy.2016.0676.
    PubMed     Text format     Abstract available


  52. HONG MJ, Na DG, Baek JH, Sung JY, et al
    Cytology-Ultrasonography (CU) Risk Stratification Scoring System Based on Fine-needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System (K-TIRADS).
    Thyroid. 2017 May 2. doi: 10.1089/thy.2016.0603.
    PubMed     Text format     Abstract available


  53. CHUNG SR, Baek JH, Park HS, Choi YJ, et al
    Ultrasound-Pathology Discordant Nodules on Core-Needle Biopsy: Malignancy Risk and Management Strategy.
    Thyroid. 2017;27:707-713.
    PubMed     Text format     Abstract available


    April 2017
  54. RUBIO GA, Koru-Sengul T, Vaghaiwalla TM, Parikh PP, et al
    Postoperative Outcomes in Graves' Disease Patients: Results from the Nationwide Inpatient Sample Database.
    Thyroid. 2017 Apr 29. doi: 10.1089/thy.2016.0500.
    PubMed     Text format     Abstract available


  55. OH HS, Kim WG, Park S, Kim M, et al
    Serial neck ultrasonographic evaluation of changes in papillary thyroid carcinoma during pregnancy.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0618.
    PubMed     Text format     Abstract available


  56. KIM H, Kim TH, Choe JH, Kim JH, et al
    Patterns of initial recurrence in completely resected papillary thyroid carcinoma.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0648.
    PubMed     Text format     Abstract available


  57. YANG Z, Flores J, Katz S, Nathan CA, et al
    Comparison of survival outcomes following post-surgical radioactive iodine versus external beam radiation in stage IV differentiated thyroid carcinoma.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0650.
    PubMed     Text format     Abstract available


  58. MA C, Feng F, Wang S, Fu H, et al
    Chinese data of efficacy of low- and high-dose of iodine-131 for the ablation of thyroid remnant.
    Thyroid. 2017 Apr 12. doi: 10.1089/thy.2015.0658.
    PubMed     Text format     Abstract available


  59. PAULSON VA, Shivdasani P, Angell TE, Cibas ES, et al
    Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Thyroid. 2017;27:506-511.
    PubMed     Text format     Abstract available


  60. MUJAMMAMI M, Tamilia M
    Response to Tulchinsky and Avram re: "Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine".
    Thyroid. 2017;27:592.
    PubMed     Text format    


    March 2017
  61. IYAMA K, Matsuse M, Mitsutake N, Rogounovitch T, et al
    Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET in Thyroid Cancers of Young Patients in Fukushima.
    Thyroid. 2017 Mar 29. doi: 10.1089/thy.2016.0673.
    PubMed     Text format     Abstract available


  62. BONHOMME B, Godbert Y, Perot G, Alghuzlan A, et al
    Molecular pathology of anaplastic thyroid carcinomas: a retrospective study of 144 cases.
    Thyroid. 2017 Mar 28. doi: 10.1089/thy.2016.0254.
    PubMed     Text format     Abstract available


  63. TAVARELLI M, Sarfati J, Chereau N, Tissier F, et al
    Heterogeneous prognoses for pT3 papillary thyroid carcinomas and impact of delayed risk stratification.
    Thyroid. 2017 Mar 28. doi: 10.1089/thy.2016.0512.
    PubMed     Text format     Abstract available


  64. IZKHAKOV E, Barchana M, Liphshiz I, Silverman B, et al
    Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel.
    Thyroid. 2017 Mar 24. doi: 10.1089/thy.2016.0481.
    PubMed     Text format     Abstract available


  65. LANG BH, Woo YC, Chiu KW
    Single-Session High-Intensity Focused Ultrasound Treatment in Large-Sized Benign Thyroid Nodules.
    Thyroid. 2017 Mar 22. doi: 10.1089/thy.2016.0664.
    PubMed     Text format     Abstract available


  66. NICKEL B, Brito JP, Barratt A, Jordan S, et al
    Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.
    Thyroid. 2017 Mar 21. doi: 10.1089/thy.2016.0483.
    PubMed     Text format     Abstract available


  67. LEE SE, Hwang TS, Choi YL, Kim WY, et al
    Molecular profiling of papillary thyroid carcinoma in Korea with high prevalence of BRAF V600E mutation.
    Thyroid. 2017 Mar 15. doi: 10.1089/thy.2016.0547.
    PubMed     Text format     Abstract available


  68. CIPRIANI NA, Agarwal S, Dias-Santagata D, Faquin WC, et al
    Clear cell change in thyroid carcinoma: a clinicopathologic and molecular study with identification of variable genetic anomalies.
    Thyroid. 2017 Mar 15. doi: 10.1089/thy.2016.0631.
    PubMed     Text format     Abstract available


  69. SHAH SA, Adam MA, Thomas S, Scheri RP, et al
    Racial Disparities In Differentiated Thyroid Cancer: Have We Bridged The Gap?
    Thyroid. 2017 Mar 15. doi: 10.1089/thy.2016.0626.
    PubMed     Text format     Abstract available


  70. ZANELLA AB, Scheffel RS, Pasa M, Dora JM, et al
    The Role of Postoperative Stimulated Thyroglobulin as Prognostic Factor for Differentiated Thyroid Cancer in Children and Adolescents.
    Thyroid. 2017 Mar 14. doi: 10.1089/thy.2016.0559.
    PubMed     Text format     Abstract available


    February 2017
  71. MOON S, Song YS, Kim YA, Lim JA, et al
    Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis.
    Thyroid. 2017 Feb 9. doi: 10.1089/thy.2016.0350.
    PubMed     Text format     Abstract available


    January 2017
  72. XU B, Tallini G, Scognamiglio T, Roman BR, et al
    Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    Thyroid. 2017 Jan 30. doi: 10.1089/thy.2016.0649.
    PubMed     Text format     Abstract available


  73. MURATA T, Iwadate M, Takizawa Y, Miyakoshi M, et al
    An adult mouse thyroid side population cell line that exhibits enriched epithelial-to-mesenchymal transition.
    Thyroid. 2017 Jan 27. doi: 10.1089/thy.2016.0130.
    PubMed     Text format     Abstract available


  74. GRIFFIN A, Brito JP, Bahl M, Hoang JK, et al
    Applying criteria of active surveillance to low-risk thyroid papillary cancer over a decade: How many surgeries and complications can be avoided?
    Thyroid. 2017 Jan 26. doi: 10.1089/thy.2016.0568.
    PubMed     Text format     Abstract available


  75. HAUGEN BR MD, Sawka AM, Alexander EK, Bible KC, et al
    The ATA Guidelines on Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of eFVPTC without Invasion to NIFTP.
    Thyroid. 2017 Jan 23. doi: 10.1089/thy.2016.0628.
    PubMed     Text format     Abstract available


  76. CHOI YJ, Baek JH, Park HS, Shim WH, et al
    A computer-aided diagnosis system using artificial intelligence for the diagnosis and characterization of thyroid nodules on ultrasound: initial clinical assessment.
    Thyroid. 2017 Jan 10. doi: 10.1089/thy.2016.0372.
    PubMed     Text format     Abstract available


  77. ESZLINGER M, Bohme K, Ullmann M, Gorke F, et al
    Evaluation of a two-year routine application of molecular testing of thyroid fine needle aspirations (FNA) using a 7-gene-panel in a primary referral setting in Germany.
    Thyroid. 2017 Jan 10. doi: 10.1089/thy.2016.0445.
    PubMed     Text format     Abstract available


  78. PAEPEGAEY AC, Cochand-Priollet B, Louiset E, Sarfati PO, et al
    Long-term control of hypercortisolism by vandetanib in a medullary thyroid carcinoma with a somatic RET mutation.
    Thyroid. 2017 Jan 9. doi: 10.1089/thy.2016.0334.
    PubMed     Text format     Abstract available


  79. RAO SN, Zafereo M, Dadu R, Busaidy N, et al
    Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.
    Thyroid. 2017 Jan 9. doi: 10.1089/thy.2016.0395.
    PubMed     Text format     Abstract available


  80. ALEXANDER EK, Pearce EN, Brent GA, Brown RS, et al
    2016 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum.
    Thyroid. 2017 Jan 6. doi: 10.1089/thy.2016.0457.
    PubMed     Text format     Abstract available


  81. ITO M, Miyauchi A, Fujiwara M, Yoshioka W, et al
    Biochemical markers reflecting thyroid function in athyreotic patients on levothyroxine monotherapy.
    Thyroid. 2017 Jan 5. doi: 10.1089/thy.2016.0426.
    PubMed     Text format     Abstract available


  82. CAVALLO A, Johnson DN, White MG, Siddiqui S, et al
    Thyroid nodule size at ultrasound as a predictor of malignancy and final pathologic size.
    Thyroid. 2017 Jan 4. doi: 10.1089/thy.2016.0336.
    PubMed     Text format     Abstract available


  83. VAN DER WARDT RA, Persoon AC, Klein Hesselink EN, Links TP, et al
    Long-term follow-up for differentiated thyroid carcinoma patients - a reconsideration.
    Thyroid. 2017 Jan 3. doi: 10.1089/thy.2016.0314.
    PubMed     Text format     Abstract available


  84. XU B, Tuttle RM Md, Sabra M, Ganly I, et al
    Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinico-Pathologic and Molecular Characteristics.
    Thyroid. 2017 Jan 3. doi: 10.1089/thy.2016.0582.
    PubMed     Text format     Abstract available


  85. AZMAT U, Porter K, Senter L, Ringel MD, et al
    Thyroglobulin Liquid Chromatography-Tandem Mass Spectrometry Has a Low Sensitivity for Detecting Structural Disease in Patients with Antithyroglobulin Antibodies.
    Thyroid. 2017;27:74-80.
    PubMed     Text format     Abstract available


    December 2016
  86. SHEN FC, Hsieh CJ, Huang IC, Chang YH, et al
    Dynamic risk estimates of outcome in Chinese patients with well-differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation.
    Thyroid. 2016 Dec 22. doi: 10.1089/thy.2016.0479.
    PubMed     Text format     Abstract available


  87. HAYMART MR, Pearce EN
    How Much Should Thyroid Cancer Impact Plans for Pregnancy?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    November 2016
  88. PARK S, Kim WG, Song E, Oh HS, et al
    Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated without Radioactive Iodine Remnant Ablation Therapy.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  89. SHAHA MA, Wang LY, Migliacci JC, Palmer FL, et al
    Previous external beam radiation treatment exposure does not confer worse outcome for patients with differentiated thyroid cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  90. CORDIOLI MI, Moraes L, Bastos AU, Besson P, et al
    Fusion oncogenes are the main genetic events found in sporadic papillary thyroid carcinomas from children.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  91. RAKHLIN L, Fish S, Tuttle RM Md
    Response to therapy status is an excellent predictor of pregnancy-associated structural disease progression in patients previously treated for differentiated thyroid cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  92. LUBITZ CC, De Gregorio L, Fingeret AL, Economopoulos KP, et al
    Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  93. NIKITSKI A, Rogounovitch T, Bychkov A, Takahashi M, et al
    Genotype analyses in the Japanese and Belarusian populations reveal independent effects of rs965513 and rs1867277 but do not support the role of FOXE1 polyalanine tract length in conferring risk for papillary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  94. JI Q, Shi R, Qu N, Luo T, et al
    Programmed death-ligand 1 expression in papillary thyroid cancer and its correlation with clinicopathological factors and recurrence.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  95. ALZAHRANI AS, Murugan AK, Qasem E, Alswailem M, et al
    Single Point Mutations in Pediatric Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  96. RAGO T, Scutari M, Loiacono V, Santini F, et al
    Low elasticity of thyroid nodules at ultrasound elastography is correlated with malignancy, degree of fibrosis and high expression of galectin-3 and fibronectin-1.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    October 2016
  97. WEINBERGER P, Ponny SR, Xu H, Bai S, et al
    Cell Cycle M-phase Genes are Highly Upregulated in Anaplastic Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  98. CASTELBLANCO E, Zafon C, Maravall J, Gallel P, et al
    APLP2, RRM2 and PRC1: new putative markers for the differential diagnosis of thyroid follicular lesions.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  99. SANDULACHE VC, Williams MD, Lai SY, Lu C, et al
    Real-time genomic characterization utilizing circulating cell-free DNA in patients with anaplastic thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  100. RABINOWITS G, Barletta J, Sholl LM, Reche E, et al
    Successful Management of a Patient with Malignant Thyroid Teratoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  101. JEONG HS, Choi EK, Song IU, Chung YA, et al
    Differences in brain glucose metabolism during preparation for I-131 ablation in thyroid cancer patients: Thyroid hormone withdrawal versus recombinant human thyrotropin.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  102. KIM SK, Park I, Hur N, Lee JH, et al
    Should Level V Be Routinely Dissected in N1b Papillary Thyroid Carcinoma?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  103. CORREA NL, de Sa LV, Corbo R
    Estimation of second primary cancer risk after treatment with radioactive iodine for differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  104. MERTEN MM, Castro MR, Zhang J, Durski JM, et al
    Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography (PET/CT) in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid Nodules.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  105. WANG Q, Yang H, Wu L, Yao J, et al
    Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathological Characteristics and BRAF-mutation in Papillary Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  106. BHALLA S, Monga D, Soni T, Gaurang A, et al
    Competency Education of Primary Care Physicians in Management of Thyroid Disorders: Implementation Experiences from a Pan India Certificate Course.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  107. LANG BH, Shek T, Chan AO, Lo CY, et al
    Significance of size of persistent/recurrent central nodal disease on surgical morbidity and response to therapy in reoperative neck dissection for papillary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  108. KIM SK, Park I, Woo JW, Lee JH, et al
    Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size < 4 cm.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  109. KIM M, Kim WG, Park S, Kwon H, et al
    The Initial Size of Metastatic Lesions is the Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  110. ROSSING RM, Jentzen W, Nagarajah J, Bockisch A, et al
    Serum thyroglobulin doubling time in progressive thyroid cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  111. LEE SG, Lee WK, Lee HS, Moon J, et al
    Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  112. GAVRILA A, Hasselgren PO, Glasgow A, Doyle AN, et al
    Variable Cold-induced Brown Adipose Tissue Response to Thyroid Hormone Status.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  113. NAJAFIAN A, Noureldine SI, Azar F, Atallah C, et al
    RAS Mutations, RET/PTC and PAX8/PPAR-gamma Chromosomal Rearrangements Are Also Prevalent in Benign Thyroid Lesions? Implications Thereof and, A Systematic Review.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  114. TULCHINSKY M, Avram A
    Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine: Patient Cohort Definition Makes No Sense.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  115. HONG S, Yu S, Li J, Yin Y, et al
    MiR-20b Displays Tumor Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    September 2016
  116. XU JY, Grubbs EG, Waguespack SG, Jimenez C, et al
    Medullary Thyroid Carcinoma Associated with Germline RET K666N Mutation.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  117. AHN HS, Kim HJ, Kim KH, Lee YS, et al
    Thyroid cancer screening in South Korea increases detection of papillary cancers with no impact on other subtypes or thyroid cancer mortality.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  118. TOMODA C, Sugino K, Matsuzu K, Uruno T, et al
    Cervical lymph node metastases after thyroidectomy for papillary thyroid carcinoma usually remain stable for years.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  119. GRUBBS EG, Williams MD, Scheet P, Vattathil S, et al
    The role of CDKN2C copy number in sporadic medullary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  120. REN Y, Lence-Anta JJ, Pereda C, Chappa M, et al
    Foxe1 Polymorphism Interacts with Dietary Iodine Intake in Differentiated Thyroid Cancer Risk in the Cuban Population.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  121. PANKRATZ DG, Hu Z, Kim SY, Monroe RJ, et al
    Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  122. ESSIG G JR, Porter K, Schneider DF, Arpaia D, et al
    MULTIFOCALITY IN SPORADIC MEDULLARY THYROID CARCINOMA: AN INTERNATIONAL MULTICENTER STUDY.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  123. SINGER S, Husson O, Tomaszewska IM, Locati L, et al
    Quality of life priorities in patients with thyroid cancer - a multi-national EORTC phase I study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  124. YOUNGWIRTH L, Abdelgadir Adam M, Scheri R, Roman S, et al
    Extrathyroidal Extension is Associated with Compromised Survival in Patients with Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    August 2016
  125. WILTSHIRE JJ, Drake TM, Uttley L, Balasubramanian SP, et al
    Systematic Review of Trends in the Incidence Rates of Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  126. DA FONSECA FL, Yamanaka PK, Kato JM, Matayoshi S, et al
    LACRIMAL SYSTEM OBSTRUCTION AFTER RADIOIODINE THERAPY IN DIFFERENTIATED THYROID CARCINOMAS: A PROSPECTIVE COMPARATIVE STUDY.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  127. IPPOLITO S, Ippolito R, Peirce C, Esposito R, et al
    Recombinant Human Thyroid Stimulating Hormone Improves Endothelial Coronary Flow Reserve in Thyroidectomized Patients With Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  128. SCHEFFEL RS, Zanella AB, Dora JM, Maia AL, et al
    Timing of radioactive iodine administration does not influence outcomes in patients with differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  129. ESPINOSA DE YCAZA AE, Lowe KM, Dean DS, Castro MR, et al
    Risk of Malignancy in Thyroid Nodules with Non-diagnostic Fine Needle Aspiration: A Retrospective Cohort Study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  130. PIRES B, Alves-Junior PA, Bordallo MA, Bulzico DA, et al
    Prognostic factors for early and long-term remission in pediatric differentiated thyroid cancer: the role of gender, age, clinical presentation and the newly proposed American Thyroid Association risk stratification system.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  131. PRAGER G, Koperek O, Mayerhofer M, Muellauer L, et al
    Sustained Response to Vemurafenib in an BRAF V600E-mutated Anaplastic Thyroid Carcinoma Patient.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  132. ONODA N, Sugino K, Higashiyama T, Kammori M, et al
    The safety and efficacy of weekly paclitaxel administration for anaplastic thyroid cancer patients: A nationwide prospective study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  133. LIKHTEROV I, Osorio M, Moubayed SP, Hernandez-Prera J, et al
    The Ethical Implications of the Reclassification of Non Invasive-Follicular Variant Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  134. XU B, Ibrahimpasic T, Wang LY, Sabra M, et al
    Clinico-Pathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  135. NIXON IJ, Simo R, Newbold K, Rinaldo A, et al
    Management of Invasive Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    July 2016
  136. CUI K, Zhang M, Fu C, Ma X, et al
    Comment on "Partially Cystic Thyroid Nodules on Ultrasound: Probability of Malignancy and Sonographic Differentiation".
    Thyroid. 2016.
    PubMed     Text format    


  137. KIM SH, Roh JL, Gong G, Cho KJ, et al
    Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-up.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  138. STRICKLAND KC, Vivero M, Jo VY, Lowe AC, et al
    Pre-operative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): A Prospective Analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  139. ZHANG M, Luo Y, Zhang Y, Tang J, et al
    Efficacy and safety of ultrasound guided radiofrequency ablation for treating low risk papillary thyroid microcarcinoma: a prospective study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  140. LEE DY, Won JK, Choi HS, Park DJ, et al
    Recurrence and survival after gross total removal of resectable undifferentiated or poorly differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  141. OPSAHL EM, Schlichting E, Helset K, Svartberg J, et al
    A Nationwide study of multiple endocrine neoplasia type 2A in Norway. Predictive avd prognostic factors for the clinical course of medullary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  142. RATZON NZ, Uziely B, de Boer AG, Rottenberg Y, et al
    Unemployment risk and decreased income 2 and 4 years after thyroid cancer diagnosis: a population based study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  143. ATALLAH V, Hocquelet A, Do Cao C, Zerdoud S, et al
    Activity and safety of Sunitinib in patients with advanced radio-iodine refractory thyroid carcinoma: a retrospective analysis of 57 patients.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    June 2016
  144. HYUN YG, Alhashemi A, Fazelzad R, Goldberg AS, et al
    A Systematic Review of Unmet Information and Psychosocial Support Needs of Adults Diagnosed with Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  145. MALANDRINO P, Russo M, Regalbuto C, Pellegriti G, et al
    The Outcome Of The Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  146. JENDRZEJEWSKI JP, Liyanarachchi S, Nagy R, Senter L, et al
    Papillary thyroid carcinoma: Association between germline DNA variant markers and clinical parameters.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  147. BERNSTEIN MB, Chang EL, Amini B, Pan H, et al
    SPINE STEREOTACTIC RADIOSURGERY FOR PATIENTS WITH METASTATIC THYROID CANCER - Secondary analysis of Phase I/II trials.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  148. KIM SK, Park I, Woo JW, Lee JH, et al
    Follicular and Diffuse Sclerosing Variant Papillary Thyroid Carcinomas as Independent Predictive Factors of Loco-regional Recurrence: A Comparison Study Using Propensity Score Matching.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  149. VALDERRABANO P, Montilla Soler J, Mifsud MJ, Leon ME, et al
    Hypermetabolism on 18F-FDG PET scan does not influence the interpretation of thyroid cytopathology and nodules with SUVmax <2.5 are not at increased risk for malignancy.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  150. BRITO JP, Bleyer A
    Impact of thyroid cancer on the incidence and survival of adolescents and young adults with cancer.
    Thyroid. 2016.
    PubMed     Text format    


  151. HIRSCH D, Shohat T, Gorshtein A, Robenshtok E, et al
    Incidence of Non-thyroidal Primary Malignancy and the Association with I-131 Treatment in Patients with Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  152. GULEC SA, Kuker RA
    The Clinical Value of I-124 PET/CT Imaging in Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format    


  153. SHRESTHA RT, Evasovich MR, Amin K, Radulescu A, et al
    Correlation between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules - A Two Year Institutional Experience.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  154. WHITE MG, Cipriani NA, Abdulrasool L, Kaplan SP, et al
    Radiation Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease Free Survival.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  155. JINDAL A, Khan U
    Is Thyroglobulin level by LC-MS/MS always reliable for follow-up of DTC after Thyroidectomy: A report of 2 cases.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  156. VALDERRABANO P, Klippenstein DL, Tourtelot JB, Ma Z, et al
    The new ATA sonographic patterns for thyroid nodules perform well in medullary thyroid carcinoma: Institutional experience, systematic review and meta-analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  157. PANI F, Atzori F, Baghino G, Boi F, et al
    HYPOTHYROIDISM AND THYROID AUTOIMMUNITY AS A PROGNOSTIC BIOMARKER OF BETTER RESPONSE IN METASTATIC CANCER LONG SURVIVORS TREATED WITH SUNITINIB.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  158. ANDERSON K, Youngwirth L, Scheri R, Stang M, et al
    T1a vs T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  159. CAMPENNI A, Giovanella L, Siracusa M, Alibrandi A, et al
    99mTc-METHOXY-ISOBUTYL-ISONITRILE (MIBI) SCINTIGRAPHY IS A USEFUL TOOL FOR ASSESSING THE RISK OF MALIGNANCY IN THYROID NODULES WITH INDETERMINATE FINE NEEDLE CYTOLOGY (FNAC).
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  160. SHARMA A, Jasim S, Reading CC, Ristow K, et al
    Clinical Presentation and Diagnostic Challenges of Thyroid Lymphoma - A Cohort Study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  161. RUIZ-FERRER M, Fernandez RM, Navarro E, Antinolo G, et al
    The G534E variant in <i>HABP2</i> and Nonmedullary Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    May 2016
  162. WONG KS, Angell TE, Strickland KC, Alexander EK, et al
    Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  163. DANIELS GH
    Follicular Variant of Papillary Thyroid Carcinoma: Hybrid or Mixture.
    Thyroid. 2016.
    PubMed     Text format    


  164. KIST JW, de Keizer B, Vogel WV
    Letter to the Editor regarding the article "I-124 PET/CT in patients with differentiated thyroid cancer: clinical and quantitative image analysis".
    Thyroid. 2016.
    PubMed     Text format    


  165. LEE SE, Hwang TS, Choi YL, Han HS, et al
    Prognostic significance of TERT promoter mutations in papillary thyroid carcinomas in a BRAF V600E mutation-prevalent population.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  166. HODAK S, Tuttle RM Md, Maytal G, Nikiforov YE, et al
    Changing the Cancer Diagnosis - the Case of Follicular Variant of Papillary Thyroid Cancer Primum, Non Nocere and NIFTP.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  167. WU JX, Young S, Hung M, Li N, et al
    Clinical Factors Influencing the Performance of Gene Expression Classifier Testing in Indeterminate Thyroid Nodules.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  168. GOLDFARB M, Casillas J
    Thyroid Cancer Specific Quality of Life and Health Related Quality of Life in Young Adult Thyroid Cancer Survivors.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  169. MUJAMMAMI MH, Hier MP, Payne RJ, Rochon L, et al
    Long-term Outcomes of Patients with Papillary Thyroid Cancer undergoing Remnant Ablation with 30 milliCuries Radioiodine.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    April 2016
  170. CAZARIN JM, Coelho RG, Hecht F, Andrade BM, et al
    5 -AMP-activated Protein Kinase (AMPK) Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion and Epithelial-to-Mesenchymal Transition.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  171. LA COUR JL, Andersen UB, Sorensen CH, Nygaard B, et al
    Radioiodine Therapy Does Not Change the Atherosclerotic Burden of the Carotid Arteries.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  172. DU E, Wenig B, Su HK, Rowe ME, et al
    Inter-observer Variation in the Pathologic Identification of Extranodal Extension in Nodal Metastasis from Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  173. HAKALA TT, Kholova I
    Changes in classification of follicular thyroid cancers.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    March 2016
  174. LATROFA F, Ricci D, Sisti E, Piaggi P, et al
    Significance of low levels of thyroglobulin autoantibodies associated with undetectable thyroglobulin after thyroidectomy for differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  175. JEON M, Chun SM, Kim D, Kwon H, et al
    Genomic alterations of anaplastic thyroid carcinoma detected by targeted massive parallel sequencing in a BRAFV600E mutation-prevalent area.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  176. KIM SK, Woo JW, Park I, Lee JH, et al
    Influence of Body Mass Index and Body Surface Area on the Behavior of Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  177. LEE YH, Seo HS, Suh SI, Ryoo I, et al
    A Feasibility Study of a Contrast-Enhanced Multi-detector CT (64 channels) Protocol for Papillary Thyroid Carcinoma: The Influence of Different Scan Delays on Tumor Conspicuity.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  178. SU HK, Wenig B, Haser GC, Rowe ME, et al
    Inter-observer Variation in the Pathologic Identification of Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  179. ARAGON HAN P, Kim HS, Cho S, Fazeli R, et al
    Association of BRAF Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  180. BRITO JP, Kim HJ, Han SJ, Lee YS, et al
    Geographic distribution and evolution of thyroid cancer epidemic in South Korea.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    February 2016
  181. LIN JD, Fu SS, Chen JY, Lee CH, et al
    Clinical Manifestations and Gene Expression in Patients with Conventional Papillary Thyroid Carcinoma Carrying the BRAFV600E Mutation and BRAF Pseudogene.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  182. NIXON IJ, Wang LY, Migliacci JC, Eskander A, et al
    An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  183. URKEN ML, Haser GC, Likhterov I, Wenig B, et al
    The impact of metastatic lymph nodes on risk stratification in differentiated thyroid cancer: Have we reached a higher level of understanding?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  184. KOWALSKA A, Walczyk A, Kowalik A, Palyga I, et al
    Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF Mutation: A Single-Institution Study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  185. SABRA MM, Ghossein R, Tuttle RM
    Time Course and Predictors of Structural Disease Progression in Pulmonary Metastases Arising from Follicular Cell-Derived Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  186. GANDHI A, Wong KK, Gross M, Avram A, et al
    Lingual Thyroid Ectopia: Diagnostic SPECT/CT imaging and Radioactive Iodine Treatment.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  187. BERBER E, Bernet V, Fahey T 3rd, Kebebew E, et al
    American Thyroid Association Statement on Remote Access Thyroid Surgery.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  188. GULEC SA, Kuker RA, Goryawala M, Fernandez C, et al
    I-124 PET/CT IN PATIENTS WITH DIFFERENTIATED THYROID CANCER: CLINICAL AND QUANTITATIVE IMAGE ANALYSIS.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  189. BAKKAR S, Frustaci G, Papini P, Fregoli L, et al
    Track Recurrence After Robotic Transaxillary Thyroidectomy; A Case Report Highlighting The Importance of Controlled Surgical Indications and Addressing Unprecedented Complications.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  190. GRECO A, Albanese S, Auletta L, Mirabelli P, et al
    High-frequency ultrasound-guided injection for the generation of a novel orthotopic mouse model of human thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  191. ROSARIO PW, Carvalho M, Mourao GF, Calsolari MR, et al
    Comparison of antithyroglobulin antibodies concentrations before and after ablation with 131I as predictor of structural disease in differentiated thyroid carcinoma patients with undetectable basal thyroglobulin and negative neck ultrasonography.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  192. BALACHANDAR S, La Quaglia M, Tuttle RM, Heller G, et al
    Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes.
    Thyroid. 2016;26:219-26.
    PubMed     Text format     Abstract available


    January 2016
  193. HEATON CM, Chang JL, Orloff LA
    Prognostic implications of lymph node yield in central and lateral neck dissections for well-differentiated papillary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  194. SUH CH, Baek JH, Choi YJ, Lee JH, et al
    Efficacy and safety of radiofrequency and ethanol ablation for treating locally recurrent thyroid cancer: A systematic review and meta-analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  195. KITAHARA CM, McCullough M, Franceschi S, Rinaldi S, et al
    Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  196. ANGELL TE, Lechner MG, Smith AM, Martin SE, et al
    Circulating Myeloid Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  197. NA DG, Baek JH, Sung JY, Kim JH, et al
    Thyroid Imaging Reporting and Data System for Risk Stratification of Thyroid Nodules: Categorization Based on Solidity and Echogenicity.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  198. AHN HY, Chung YJ, Park KY, Cho BY, et al
    Serum 25-Hydroxyvitamin D Level Does Not Affect the Aggressiveness and Prognosis of Papillary Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  199. BRITO JP, Ito Y, Miyauchi A, Tuttle RM, et al
    A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
    Thyroid. 2016;26:144-9.
    PubMed     Text format     Abstract available


    December 2015
  200. LEE L, Mitmaker EJ, Chabot JA, Lee JA, et al
    Cost-Effectiveness of Diagnostic Lobectomy Versus Observation for Thyroid Nodules Greater than 4 cm.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  201. ALZAHRANI AS, Qasem E, Murugan AK, Al-Hindi HN, et al
    Uncommon TERT Promoter Mutations in Pediatric Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  202. CASTRONEVES LA, Negrao MV, Freitas RM, Papadia C, et al
    Sorafenib for the treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  203. SAWKA AM, Brierley J, Tsang RW, Rotstein L, et al
    Unmet Information Needs of Low Risk Thyroid Cancer Survivors.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  204. CHEN Y, Sadow PM, Suh H, Lee KE, et al
    BRAFV600E is correlated with recurrence of papillary thyroid microcarcinoma: A systematic review, multi-institutional primary data analysis, and meta-analysis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  205. ITO Y, Miyauchi A, Kudo T, Ota H, et al
    Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  206. SUH CH, Baek JH, Lee JH, Choi YJ, et al
    The role of core-needle biopsy as a first-line diagnostic tool for initially detected thyroid nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  207. BIKAS A, Van Nostrand D, Jensen KE, Desale S, et al
    Metformin Attenuates <sup>131</sup>I - Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  208. NIKITA ME, Jiang W, Cheng SM, Hantash FM, et al
    Mutational analysis in Pediatric Thyroid Cancer and correlations with age, ethnicity and clinical presentation.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    November 2015
  209. PITOIA F, Miyauchi A
    2015 American Thyroid Association Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer and their Implementation in Various Care Settings.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  210. KIM JW, Roh JL, Gong G, Cho KJ, et al
    Treatment Outcomes and Risk Factors for Recurrence after Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  211. ESPIARD S, Petyt G, Lion G, Beron A, et al
    Ectopic Subcutaneous Implantation of Thyroid Tissue after Gasless Transaxillary Robotic Thyroidectomy for Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  212. JEON M, Kim WG, Choi YM, Kwon H, et al
    Features predictive of distant metastasis in papillary thyroid microcarcinoma.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  213. LIU X, Medici M, Kwong N, Angell TE, et al
    Bethesda Categorization of Thyroid Nodule Cytology & Prediction of Thyroid Cancer Type and Prognosis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  214. BERNARDI S, Lanzilotti V, Papa G, Panizzo N, et al
    Full-thickness skin burn caused by radiofrequency ablation of a benign thyroid nodule.
    Thyroid. 2015.
    PubMed     Text format    


  215. DE NAPOLI L, Bakkar S, Ambrosini CE, Materazzi G, et al
    Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    October 2015
  216. HAUGEN BR MD, Alexander EK, Bible KC, Doherty G, et al
    2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  217. COURA-FILHO GB, Carvalho JW, Buchpiguel CA, Sapienza MT, et al
    Effects of thyroid hormone withdrawal and recombinant human TSH on glomerular filtration rate during radioiodine therapy for well-differentiated thyroid cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  218. AN JH, Yul H, Ahn HY, Keam B, et al
    A Possible Association Between Thyroid Cancer and Breast Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  219. CHOI YJ, Baek JH, Baek S, Shim WH, et al
    Web-based Malignancy Risk Estimation for Thyroid Nodules using Ultrasonography Characteristics: Development and Validation of a Predictive Model.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  220. KHOKHAR MT, Day KM, Sangal RB, Ahmedli NM, et al
    Preoperative High-Resolution Ultrasound for the Assessment of Malignant Central Compartment Lymph Nodes In Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  221. ASCHEBROOK-KILFOY B, James BC, Nagar S, Kaplan S, et al
    Risk Factors for Decreased Quality of Life in Thyroid Cancer Survivors: Initial Findings from the North American Thyroid Cancer Survivorship Study.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  222. PATEL DT, Kitahara CM, Park Y, Liao LM, et al
    Thyroid Cancer and Nonsteroidal Antiinflammatory Drug Use: A Pooled Analysis of Patients Over 40 years of Age.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  223. ODA H, Miyauchi A, Ito Y, Yoshioka K, et al
    Incidences of Unfavorable Events in the Management of Low-risk Papillary Microcarcinoma of the Thyroid by Active Surveillance vs. Immediate Surgery.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    September 2015
  224. FAN N, Talaga M, Brown R, Fueri A, et al
    Glycan-dependent mutual and reversible sequestration of two thyroid cancer biomarkers.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  225. COYNE C, Afkhami M, Karunamurthy A, Chiosea SI, et al
    Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF K601E Mutation.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  226. ARAGON HAN P, Weng CH, Khawaja HT, Nagarajan N, et al
    MicroRNA Expression and Association with Clinicopathologic Features in Papillary Thyroid Cancer: A Systematic Review.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  227. DANILOVIC DL, de Camargo RY, Castro G Jr, Papadia C, et al
    Rapid Control of T3 Thyrotoxicosis in Patients with Metastatic Follicular Thyroid Cancer Treated with Lenvatinib.
    Thyroid. 2015.
    PubMed     Text format    


  228. ATKINS F, Van Nostrand D, Moreau S, Burman K, et al
    Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of I.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  229. FERRIS RL, Carty SE
    Response to Letter to the Editor on COI for American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format    


  230. NIKIFOROV YE, Carty SE, Chiosea SI, Coyne C, et al
    Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  231. SHRESTHA RT, Karunamurthy A, Amin K, Nikiforov YE, et al
    Multiple Mutations Detected Preoperatively May Predict Aggressive Behavior of Papillary Thyroid Cancer and Guide Management - A Case Report.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  232. KLOOS RT, Kennedy GC
    Response to "American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making".
    Thyroid. 2015.
    PubMed     Text format    


  233. KIM D, Hwang SH, Cha J, Jo K, et al
    Risk Stratification of Thyroid Incidentalomas Found on PET/CT: The Value of Iodine Content on Noncontrast Computed Tomography.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    August 2015
  234. TOLEDO RA, Maciel RM, Erlic Z, Lourenco DM Jr, et al
    RET Y791F Variant Does Not Increase the Risk for Medullary Thyroid Carcinoma.
    Thyroid. 2015;25:973-4.
    PubMed     Text format    


    July 2015
  235. MCLEOD DS, Jonklaas J, Brierley J, Ain KB, et al
    Reassessing the NTCTCS staging systems for differentiated thyroid cancer, including age at diagnosis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  236. DADU R, Hu MI, Cleeland CS, Busaidy N, et al
    The efficacy of the natural clay, Calcium Aluminosilicate Anti-Diarrheal (CASAD), in reducing medullary thyroid cancer-related diarrhea and its effects on quality of life: a pilot study.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  237. SINGH OSPINA NM, Sebo TJ, Morris JC 3rd, Castro MR, et al
    The value of repeat thyroid fine needle aspiration biopsy in patients with a previously benign result: How often does it alter management?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  238. AL AFIF A, Williams BA, Rigby MH, Bullock M, et al
    Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  239. GANLY I, Nixon IJ, Wang LY, Palmer FL, et al
    Survival from differentiated thyroid cancer What has age got to do with it?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  240. ROSARIO PW, Calsolari MR
    What is the best criterion for repetition of fine-needle aspiration in thyroid nodules with initially benign cytology?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  241. DE BIASE D, Gandolfi G, Ragazzi M, Eszlinger M, et al
    TERT PROMOTER MUTATIONS IN THYROID PAPILLARY MICROCARCINOMAS.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  242. SEO GH, Cho YY, Chung JH, Kim SW, et al
    Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  243. WIEBEL JL, Esfandiari NH, Papaleontiou M, Worden FP, et al
    Evaluating Positron Emission Tomography Use in Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  244. VACCARELLA S, Dal Maso L, Laversanne M, Bray F, et al
    The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  245. LARRIVEE-VANIER S, Magne F, Patey N, Chanoine JP, et al
    Conserved telomere length in human ectopic thyroids: an argument against premature differentiation causing arrested migration.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  246. PITOIA F, Jerkovich F, Urciuoli C, Schmidt A, et al
    Implementing the Modified 2009 American Thyroid Association Risk Stratification System in thyroid cancer patients with low and intermediate risk of recurrence.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  247. RALHAN R, Veyhl J, Chaker S, Assi J, et al
    Immunohistochemical Subcellular Localization of Protein Biomarkers Distinguishes Benign from Malignant Thyroid Nodules: Potential for Fine Needle Aspiration Biopsy Clinical Application.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    June 2015
  248. WANG LY, Ghossein R Md, Palmer FL, Nixon IJ, et al
    Microscopic Positive Margins in differentiated thyroid cancer is not an independent predictor of local failure.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  249. BRITO JP, AlNofal A, Montori V, Hay ID, et al
    The impact of subclinical disease and mechanism of detection on the rise in thyroid cancer incidence: a population-based study in Olmsted County, Minnesota during 1935 through 2012.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    May 2015
  250. HINSON AM, Kandil E, O'Brien S, Spencer HJ, et al
    Trends in Robotic Thyroid Surgery in the United States from 2009 through 2013.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  251. DEANDREA M, Sung JY, Limone PP, Mormile A, et al
    Efficacy and Safety of Radiofrequency Ablation versus Control Condition for Nonfunctioning Benign Thyroid Nodules: A Randomized Controlled International Collaborative Trial.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  252. FERRIS RL, Baloch ZW, Bernet V, Chen A, et al
    American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: current impact on perioperative decision-making.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  253. CHOI SH, Baek JH, Lee JH, Choi YJ, et al
    Evaluation of the clinical usefulness of BRAFV600E mutation analysis of core-needle biopsy specimens in thyroid nodules with previous atypia of undetermined significance (AUS) or follicular lesions of undetermined significance (FLUS) results.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  254. MARTI JL, Davies L, Haymart MR, Roman BR, et al
    Inappropriate use of radioactive iodine for low-risk papillary thyroid cancer is most common in regions with poor access to health care.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  255. BRAUNER E, Holmes BJ, Krane J, Nishino M, et al
    Performance of the Afirma Gene Expression Classifier in Hurthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  256. MOND M, Bullock M, Yao Y, Clifton-Bligh RJ, et al
    Somatic Mutations of FOXE1 in Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  257. HANLEY JP, Jackson E, Morrissey LA, Rizzo DM, et al
    Geospatial and Temporal Analysis of Thyroid Cancer Incidence in a Rural Population.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    April 2015
  258. KIM SM, Kim HK, Chang H, Kim KJ, et al
    Recovery from Permanent Hypoparathyroidism after Total Thyroidectomy.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  259. FRANCIS G, Waguespack SG, Bauer AJ, Angelos P, et al
    Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Pediatric Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  260. NAKAMURA H, Hirokawa M, Ota H, Kihara M, et al
    Is an increase in thyroid nodule volume a risk factor for malignancy?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  261. MARTI JL, Jain KS, Morris LG
    Increased risks of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  262. YI KS, Kim JH, Na DG, Seo H, et al
    Usefulness of Core Needle Biopsy for Thyroid Nodules with Macrocalcifications: Comparison with Fine Needle Aspiration.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  263. WEISS RJ, Magner J
    Serial Measurements of Serum Thyroglobulin in Response to Recombinant Human Thyrotropin (rhTSH) Stimulation.
    Thyroid. 2015.
    PubMed     Text format    


  264. WU JX, Beni CE, Zanocco K, Sturgeon C, et al
    Cost-Effectiveness of Long-Term Every Three-Year Versus Annual Postoperative Surveillance for Low Risk Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    March 2015
  265. MORLEY S, Goldfarb M
    Support Needs and Survivorship Concerns of Thyroid Cancer Patients.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  266. RANDOLPH G, Sritharan N, Song P, Franco R, et al
    Thyroidectomy in the Professional Singer-Neural Monitored Surgical Outcomes.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  267. KEEGAN T, Grogan R, Parsons H, Tao L, et al
    Socio-demographic disparities in differentiated thyroid cancer survival among adolescents and young adults in California.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  268. KLOPPER J, Kane MA, Jimeno A, Sams S, et al
    A Phase II Trial of Bexarotene for Advanced Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  269. HOANG JK, Langer JE, Middleton WD, Wu CC, et al
    Misinterpretation of the American College of Radiology White Paper on Managing Incidental Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format    


  270. ROSARIO PW, Mourao GF, Siman TL, Calsolari MR, et al
    Serum thyroglobulin measured with a second-generation assay in patients undergoing total thyroidectomy without radioiodine remnant ablation: A prospective study.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  271. REMONTI LR, Kramer CK, Leitao CB, Pinto LC, et al
    Thyroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  272. SEMRAD T, Semrad A, Farwell DG, Chen Y, et al
    Initial Treatment Patterns in Younger Adult Patients with Differentiated Thyroid Cancer in California.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  273. MEDAPATI MR, Dahlmann M, Ghavami S, Pathak KA, et al
    RAGE mediates the pro-migratory response of extracellular S100A4 in human thyroid cancer cells.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    February 2015
  274. HAYASE S, Sasaki Y, Matsubara T, Seo D, et al
    Expression of stanniocalcin 1 in thyroid side population cells and thyroid cancer cells.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  275. PERTICONE F, Pigliaru F, Mariotti S, Deiana L, et al
    IS THE INCIDENCE OF DIFFERENTIATED THYROID CANCER INCREASED IN PATIENTS WITH TSH-SECRETING ADENOMA? REPORT OF THREE CASES FROM A LARGE CONSECUTIVE SERIES OF TSH-OMA.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    January 2015
  276. NASCIMENTO C, Borget I, Al Ghuzlan A, Deandreis D, et al
    Post-operative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT): an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  277. CHAMI L, Hartl DM, Leboulleux S, Baudin E, et al
    PREOPERATIVE LOCALIZATION OF NECK RECURRENCES FROM THYROID CANCER: CHARCOAL TATTOOING UNDER ULTRASOUND GUIDANCE.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  278. CHOUGNET CN, Borget I, Leboulleux S, de la Fouchardiere C, et al
    Vandetanib for the treatment of advanced medullary thyroid cancer outside a trial: results from a French cohort.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  279. BURYK MA, Simons JP, Picarsic JL, Monaco SE, et al
    Can malignant thyroid nodules be distinguished from benign thyroid nodules in children and adolescents by clinical characteristics? A review of 89 pediatric patients with thyroid nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  280. TUFANO R, Noureldine SI, Angelos P
    Ethical Responsibilities of Caring for Patients with Incidental Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  281. FENG X, Milas M, O'Malley M, LaGuardia L, et al
    Characteristics of Benign and Malignant Thyroid Disease in Familial Adenomatous Polyposis Patients and Recommendations for Disease Surveillance.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  282. LYLE M, Dean D
    Ultrasound Guided Fine Needle Aspiration Biopsy of Thyroid Nodules in Patients taking Novel Oral Anticoagulants.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  283. SACKS W, Wong R, Bresee C, Braunstein G, et al
    Use of Evidence-Based Guidelines Reduces I131 Treatment in Patients with Low Risk Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  284. ROGOUNOVITCH T, Bychkov A, Takahashi M, Mitsutake N, et al
    The common genetic variant rs944289 at chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in Japanese population.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    December 2014
  285. BEUTNER U, Leowardi C, Bork U, Luthi C, et al
    Survival after renal cell carcinoma metastasis to the thyroid. Single center experience and systematic review of the literature.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


    November 2014
  286. NAGARAJAN N, Schneider EB, Ali SZ, Zeiger MA Md, et al
    How Do Liquid Based Preparations of Thyroid FNA Compare with Conventional Smears? An Analysis of 5475 Specimens.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: